Today

Agents

Chat

Arena

Discover

More

App

Keros Therapeutics - Keith Regnante Resigns As CFO - KROS News | Rallies

Keros Therapeutics - Keith Regnante Resigns As CFO

KROS•2026-07-22

CFO resignation and interim appointment

Keros Therapeutics Inc. said Keith Regnante resigns as chief financial officer effective August 3, 2026.
The company appoints Annita Tanini interim principal financial officer effective August 4, 2026.
The information was disclosed in an SEC filing.

Related News

US says it reaches nuclear power deal with Saudi Arabia

BAM•2026-07-22

Penske Automotive Group Confirms Receipt Of Unsolicited, Preliminary And Non-Binding Take Private Proposal

PAG•2026-07-22

Tesla CFO Says Capex Will Grow For The Next Two Or Three Years

•

2026-07-22

Prosperity Bancshares Announces Common Stock Dividend

PB•2026-07-22

Atlasclear Holdings Signs Letter Of Intent To Acquire An Institutional Digital Asset Business And Advances Acquisition Of Dawson James Securities

ATCH•2026-07-22